12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, several health care stocks experienced significant movements. Ensysce Biosciences and Genprex saw substantial gains, while GRI Bio and Sensei Biotherapeutics faced notable declines. Medpace Holdings also declined following its Q3 earnings release.
October 22, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GRI Bio shares fell 24.7% in pre-market trading, indicating negative investor sentiment.
The decline in GRI's stock price suggests a negative market reaction, possibly due to unfavorable news or investor concerns.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Medpace Holdings shares declined by 11.32% in pre-market trading following its Q3 earnings release.
The decline in MEDP's stock price post-earnings suggests that the market may have been disappointed with the Q3 results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Sensei Biotherapeutics stock declined by 21.03% in pre-market trading, reflecting negative market sentiment.
The significant drop in SNSE's stock price indicates a negative investor reaction, likely due to recent developments or market conditions.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Ensysce Biosciences stock surged by 134.8% in pre-market trading, indicating strong investor interest.
The significant increase in ENSC's stock price suggests a positive market reaction, likely due to new developments or investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Genprex stock rose by 118.54% in pre-market trading, reflecting a strong positive sentiment.
The sharp rise in GNPX's stock price indicates a favorable market response, possibly due to recent news or investor optimism.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100